Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Stockholders' Equity

v3.25.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023   24,652,729    
Beginning balance at Dec. 31, 2023 $ 21,173 $ 247 $ 193,382 $ (172,456)
Issuances of common stock:        
Public offering of common stock (in shares)   2,653,848    
Public offering of common stock 16,183 $ 26 16,157  
Share-based compensation (in shares)   126,315    
Share-based compensation 1,504 $ 1 1,503  
Option exercises (in shares)   7,500    
Option exercises 21   21  
Payments for taxes related to net share settlement of equity awards (in shares)   (24,047)    
Payments for taxes related to net share settlement of equity awards (151)   (151)  
Net loss for the period (4,146)     (4,146)
Ending balance (in shares) at Mar. 31, 2024   27,416,345    
Ending balance at Mar. 31, 2024 $ 34,584 $ 274 210,912 (176,602)
Beginning balance (in shares) at Dec. 31, 2024 27,617,415 27,617,415    
Beginning balance at Dec. 31, 2024 $ 25,389 $ 276 216,483 (191,370)
Issuances of common stock:        
Share-based compensation (in shares)   453,832    
Share-based compensation 1,908 $ 5 1,903  
Option exercises (cash and cashless) (in shares)   7,851    
Option exercises (cash and cashless) $ 21   21  
Option exercises (in shares) 11,906      
Payments for taxes related to net share settlement of equity awards (in shares)   (98,914)    
Payments for taxes related to net share settlement of equity awards $ (1,305) $ (1) (1,304)  
Net loss for the period $ (6,026)     (6,026)
Ending balance (in shares) at Mar. 31, 2025 27,980,184 27,980,184    
Ending balance at Mar. 31, 2025 $ 19,987 $ 280 $ 217,103 $ (197,396)